BC
Broadwood Capital Portfolio holdings
AUM
$1.53B
This Quarter Return
+3.54%
1 Year Return
+36.91%
3 Year Return
+67.63%
5 Year Return
+132.65%
10 Year Return
+697.91%
AUM
$1.3B
AUM Growth
+$1.3B
(-1.4%)
Cap. Flow
-$10.2M
Cap. Flow
% of AUM
-0.78%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
$10.2M |
Sector Composition
| 1 | Healthcare | 34.7% |
| 2 | Consumer Staples | 33.2% |
| 3 | Industrials | 23.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Monster Beverage
MNST
$60.9B
| $433M | 33.2% | 8,295,690 | – | – |
|
2
STAAR Surgical
STAA
$1.36B
| $400M | 30.68% | 10,768,431 | – | – |
|
3
Axon Enterprise
AXON
$58.7B
| $304M | 23.3% | 760,062 | – | – |
|
|
4
iShares Russell 2000 ETF
IWM
$67B
| $115M | 8.81% | 519,920 -46,080 | -8% | -$10.2M |
|
5
Lineage Cell Therapeutics
LCTX
$267M
| $37.7M | 2.89% | 41,666,255 | – | – |
|
|
IMDX
6
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $14M | 1.08% | 4,929,066 | – | – |
|
7
Serina Therapeutics
SER
$54.5M
| $570K | 0.04% | 85,219 | – | – |
|